• Nie Znaleziono Wyników

Identification of occult hepatitis B and hepatitis C virus infections - Epidemiological Review

N/A
N/A
Protected

Academic year: 2021

Share "Identification of occult hepatitis B and hepatitis C virus infections - Epidemiological Review"

Copied!
2
0
0

Pełen tekst

(1)

PRZEGL EPIDEMIOL 2008; 62: 493 - 494

Tomasz I Michalak

IDENTIFICATION OF OCCULT HEPATITIS B AND HEPATITIS C VIRUS

INFECTIONS

Molecular Virology and Hepatology Research Group, Faculty of Medicine The Health Sciences Centre, Memorial University, St. John’s, NL, Canada

Słowa kluczowe: zapalenie wątroby typu C, zapalenie wątroby typu B, ukryte zakażenie, identyfikacja

Key words: hepatitis C, hepatitis B, occult hepatitis, identification

Occult hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are recently identified entities whose existence became evident when nucleic acid amplification assays of enhanced sensitivity were employed for detection of viral genomes and their replicative intermediates. These long-term, seemingly asymptomatic infections are consequences of persistent low-level viral replication progressing in hepatocytes and in cells of the immune system. Detection of these new forms of HCV and HBV infections requires a thorough testing approach in which analysis of serial serum and peripheral blood lymphoid cell samples and, when feasible, liver tissue is performed under strict contamination controlled conditions using nucleic acid amplifications targeting different regions of viral genomes. This presentation will focus on the molecular methods of identification of trace amounts of HBV and HCV genomes and their replication intermediates, procedures of enhancing virus detection in immune cells, and on outlining general characteristics of occult HCV and HBV persistence. Data from the experimental woodchuck model of hepatitis B, which contributed to recognition of the natural course, virological properties and immunological characteristics of occult HBV infection, will be also acknowledged.

T I Michalak

(2)

T I Michalak

494

Nr 3

Adres autora:

Tomasz I. Michalak MD, PhD

Professor of Molecular Virology and Medicine (Hepatology) Senior Canada Research Chair in Viral Hepatitis/Immunology Molecular Virology and Hepatology Research Group Faculty of Medicine

The Health Sciences Centre Memorial University

St. John’s, NL, Canada A1B 3V6 e-mail: timich@mun.ca

Cytaty

Powiązane dokumenty

Concerning the correlation between sTLR4 and clinico- pathological parameters, significant positive correlations of sTLR4 with serum AST activity, serum total bilirubin, se- rum

Studying cases with risk factors other than family history, 33.3% of them showed higher levels of viraemia (high and very high levels) to- gether with ALT in ULN, while 66.6% of

Analizując wpływ alleli HLA na aktywność ALT, będą- cą wskaźnikiem klinicznym przebiegu zakażenia HCV, nie stwierdzono istotnych zależności – ani w analizie zbiorczej

Jeśli do zakażenia dochodzi dro- gą wertykalną lub inną (parenteralną, horyzontalną) w pierwszych latach życia, z uwagi na niedobory odpor- ności, a zwłaszcza niesprawne

Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C

Administration of all doses in the second series, on an appropriate schedule, followed by anti-HBs testing 1 to 2 months after the final dose, is usually more practical than

Pierwotny zespół Sjögrena czy objawy wywołane przez zakażenie wirusem zapalenia wątroby typu C?. Primary Sjögren’s syndrome or manifestations of hepatitis C

Sprawna komunikacja, przepływ informacji i wie- dzy są także warunkami rozwoju internacjonalizacji, wpływają bowiem na wzrost świadomości działań podejmowanych w